Scholar Rock

Focused on treating serious diseases where protein growth factors play a fundamental role

Scholar Rock is focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia.

Status
NASDAQ: SRRK
Year of Investment
2020
Strategy
Life Sciences
Location
Cambridge, Massachusetts